<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/1999/REC-html401-19991224/loose.dtd">
<html><head><title>Details for gene set LI_PROSTATE_CANCER_EPIGENETIC[GSEA]</title><link href='xtools.css' rel='stylesheet'><link href='http://www.gsea-msigdb.org/gsea/images/XBench.gif' rel='shortcut icon'></head><body><div class='keyValTable'><table cols='2' border='0'><th class='keyValTable'></th><th class='keyValTable'></th><tr><td>Dataset</td><td>RG_DM_nDM</td></tr><tr><td>Phenotype</td><td>NoPhenotypeAvailable</td></tr><tr><td>Upregulated in class</td><td>na_neg</td></tr><tr><td>GeneSet</td><td>LI_PROSTATE_CANCER_EPIGENETIC</td></tr><tr><td>Enrichment Score (ES)</td><td>-0.67812675</td></tr><tr><td>Normalized Enrichment Score (NES)</td><td>-1.835072</td></tr><tr><td>Nominal p-value</td><td>0.0037243948</td></tr><tr><td>FDR q-value</td><td>0.67312604</td></tr><tr><td>FWER p-Value</td><td>0.803</td></tr><caption class='table'>Table: GSEA Results Summary</caption></table></div><br><div class='image'><img name='enplot_LI_PROSTATE_CANCER_EPIGENETIC' src='enplot_LI_PROSTATE_CANCER_EPIGENETIC_43.png'><br><br><caption>Fig 1: Enrichment plot: LI_PROSTATE_CANCER_EPIGENETIC &nbsp&nbsp <br> Profile of the Running ES Score & Positions of GeneSet Members on the Rank Ordered List</caption></div><br><div class='richTable'><table cols='8' border='1'><th class='richTable'></th><th class='richTable'>PROBE</th><th class='richTable'>GENE SYMBOL</th><th class='richTable'>GENE_TITLE</th><th class='richTable'>RANK IN GENE LIST</th><th class='richTable'>RANK METRIC SCORE</th><th class='richTable'>RUNNING ES</th><th class='richTable'>CORE ENRICHMENT</th><tr><td class='lessen'>1</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=PTGS2'>PTGS2</a></td><td></td><td></td><td>851</td><td>0.941</td><td>-0.0078</td><td>No</td></tr><tr><td class='lessen'>2</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=ESR2'>ESR2</a></td><td></td><td></td><td>1798</td><td>0.593</td><td>-0.0482</td><td>No</td></tr><tr><td class='lessen'>3</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=PXMP4'>PXMP4</a></td><td></td><td></td><td>4034</td><td>0.174</td><td>-0.2293</td><td>No</td></tr><tr><td class='lessen'>4</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=GSTP1'>GSTP1</a></td><td></td><td></td><td>5006</td><td>0.055</td><td>-0.3094</td><td>No</td></tr><tr><td class='lessen'>5</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=CAV1'>CAV1</a></td><td></td><td></td><td>5907</td><td>-0.039</td><td>-0.3846</td><td>No</td></tr><tr><td class='lessen'>6</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=CDH1'>CDH1</a></td><td></td><td></td><td>6176</td><td>-0.067</td><td>-0.4030</td><td>No</td></tr><tr><td class='lessen'>7</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=MGMT'>MGMT</a></td><td></td><td></td><td>7457</td><td>-0.225</td><td>-0.4980</td><td>No</td></tr><tr><td class='lessen'>8</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=PLAU'>PLAU</a></td><td></td><td></td><td>7711</td><td>-0.262</td><td>-0.5016</td><td>No</td></tr><tr><td class='lessen'>9</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=DAPK1'>DAPK1</a></td><td></td><td></td><td>8436</td><td>-0.377</td><td>-0.5378</td><td>No</td></tr><tr><td class='lessen'>10</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=HPSE'>HPSE</a></td><td></td><td></td><td>10059</td><td>-0.749</td><td>-0.6258</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>11</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=EDNRB'>EDNRB</a></td><td></td><td></td><td>10365</td><td>-0.869</td><td>-0.5914</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>12</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=RASSF1'>RASSF1</a></td><td></td><td></td><td>10943</td><td>-1.176</td><td>-0.5591</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>13</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=CD44'>CD44</a></td><td></td><td></td><td>11048</td><td>-1.262</td><td>-0.4798</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>14</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=CDKN2A'>CDKN2A</a></td><td></td><td></td><td>11221</td><td>-1.449</td><td>-0.3933</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>15</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=HIC1'>HIC1</a></td><td></td><td></td><td>11228</td><td>-1.457</td><td>-0.2920</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>16</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=VDR'>VDR</a></td><td></td><td></td><td>11381</td><td>-1.758</td><td>-0.1822</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>17</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=CCND2'>CCND2</a></td><td></td><td></td><td>11555</td><td>-2.848</td><td>0.0020</td><td bgcolor='#CCFFCC'>Yes</td></tr><caption class='table'>Table: GSEA details&nbsp<a href='LI_PROSTATE_CANCER_EPIGENETIC.xls'>[plain text format]</a></caption></table></div><br><div class='image'><img name='gset_rnd_es_dist' src='gset_rnd_es_dist_44.png'><br><br><caption>Fig 2: LI_PROSTATE_CANCER_EPIGENETIC: Random ES distribution &nbsp&nbsp <br> Gene set null distribution of ES for <b>LI_PROSTATE_CANCER_EPIGENETIC</b></caption></div><br></body></html>